| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000261737.1 |
Tanespimycin |
Breast invasive carcinoma |
0.04502577 |
Resistant |
| ENSG00000261737.1 |
Tanespimycin |
Chronic Lymphocytic Leukemia |
0.004600757 |
Resistant |
| ENSG00000261737.1 |
Tanespimycin |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.041755551 |
Sensitive |
